Showing 17–22 of 22 results
-
SS-31 – 250 mg Injection
SS-31 is typically administered via injection and is being studied in various clinical trials. It works by binding to the inner mitochondrial membrane, where it exerts protective effects against mitochondrial dysfunction, improves energy metabolism, and enhances the health and function of muscle tissue
-
Tesamorelin – 10 mg Injection
Tesamorelin is administered as a subcutaneous injection (under the skin), typically once a day. It works by acting as a growth hormone-releasing hormone (GHRH) analog, which stimulates the pituitary gland to release growth hormone, leading to a reduction in visceral fat.
-
Tesamorelin 10 mg Injection
Tesamorelin is administered via subcutaneous injection, typically once daily. The dosage depends on individual needs and should be determined by a healthcare provider. It works by binding to GHRH receptors in the pituitary gland, promoting the release of growth hormone.
-
Tirzepatide
Tirzepatide is administered as a weekly subcutaneous injection (under the skin). It acts as both a GLP-1 and GIP receptor agonist, which means it increases insulin release, reduces glucagon production, slows down stomach emptying, and enhances the feeling of fullness.
-
Tirzepatide – Injection
Tirzepatide is administered as a weekly subcutaneous injection (under the skin). It acts as both a GLP-1 and GIP receptor agonist, which means it increases insulin release, reduces glucagon production, slows down stomach emptying, and enhances the feeling of fullness.
-
VIP Nasal Spray
VIP nasal spray is typically administered by spraying into each nostril as directed. Dosage and frequency should be determined by a healthcare provider based on individual needs and conditions.